InnoCan Pharma (IP40) Revenue

6 Followers

InnoCan Pharma Revenue

InnoCan Pharma had a revenue of 5.29M in the quarter ending Jun 30, 2026, with -16.89%. This bring the company's revenue in the last twelve months to 23.45M, Increased -6.83%. In the fiscal year ending Dec 31, 2025, InnoCan Pharma had annual revenue of 26.61M with -9.60% growth.

Revenue (ttm)

23.45M

Revenue Growth

-23.91%

P/S Ratio

0.21

Revenue/Employee

€2,419,273

Employees

Market Cap

€5.60M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	26.61M	-2.83M	-9.60%
Mar 31, 2025	29.44M	15.78M	+115.55%
Mar 31, 2024	13.66M	11.10M	+433.69%
Dec 31, 2022	2.56M	2.36M	+1,205.61%
Mar 31, 2022	196.00K	188.00K	+2,350.00%
Mar 31, 2021	8.00K	―	+∞%
Mar 31, 2020	―	―	―
Dec 31, 2018	―	―	―